Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 3008
- Registration Number
- NCT00620516
- Locations
- 🇰🇷
Boehringer Ingelheim Investigational Site 70, Gyeongnam, Korea, Republic of
🇰🇷Boehringer Ingelheim Investigational Site 45, Jeonnam, Korea, Republic of
🇰🇷Boehringer Ingelheim Investigational Site 69, Chungbuk, Korea, Republic of
An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination
- Conditions
- Hypertension
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 259
- Registration Number
- NCT00618774
- Locations
- 🇯🇵
1235.16.001 Boehringer Ingelheim Investigational Site, Shinjyuku-ku,Tokyo, Japan
🇯🇵1235.16.006 Boehringer Ingelheim Investigational Site, Nishi-ku, Hiroshima, Hiroshima, Japan
🇯🇵1235.16.005 Boehringer Ingelheim Investigational Site, Osaka, Osaka, Japan
Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life
- Conditions
- OsteoarthritisArthritis, Rheumatoid
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2015-02-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 3569
- Registration Number
- NCT00619177
- Locations
- 🇸🇰
Boehringer Ingelheim Investigational Site, Zilina, Slovakia
Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)
- Conditions
- Parkinson Disease
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2013-11-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 3234
- Registration Number
- NCT00617019
- Locations
- 🇺🇸
248.619.01035 Emory University, Atlanta, Georgia, United States
🇺🇸248.619.01014 Northwestern University, Chicago, Illinois, United States
🇺🇸248.619.01015 John Hopkins Hospital, Baltimore, Maryland, United States
Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole
- Conditions
- Parkinson Disease
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1645
- Registration Number
- NCT00615914
- Locations
- 🇯🇵
Boehringer Ingelheim Investigational Site, Zama, Japan
Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)
- Conditions
- HIV Infections
- Interventions
- Behavioral: NO BI Drug administered
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2013-11-21
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 246
- Registration Number
- NCT00615563
- Locations
- 🇵🇷
Boehringer Ingelheim Investigational Site, Ponce, Puerto Rico
Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2016-02-08
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 754
- Registration Number
- NCT00615992
- Locations
- 🇦🇹
Boehringer Ingelheim Investigational Site, Wolkersdorf, Austria
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters
- Conditions
- Hypertension
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2014-04-07
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 3148
- Registration Number
- NCT00615108
- Locations
- 🇨🇳
Boehringer Ingelheim Investigator Site 3, Taipei, Taiwan
🇨🇳Boehringer Ingelheim Investigator Site 5, Taipei, Taiwan
🇨🇳Boehringer Ingelheim Investigator Site, Miaoli, Taiwan
Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
- Conditions
- HIV Infections
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 42
- Registration Number
- NCT00615290
- Locations
- 🇫🇷
1182.127.3301 Boehringer Ingelheim Investigational Site, Strasbourg, France
🇫🇷Boehringer Ingelheim Investigational Site, Villeneuve St G, France
RUSSE / Russian Spiriva® Safety & Efficacy Study
- Conditions
- COPD
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2014-04-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 407
- Registration Number
- NCT00613574
- Locations
- 🇷🇺
Boehringer Ingelheim Investigational Site, Yaroslavl, Russian Federation